Low Dose Naltrexone

Naltrexone, in its standard dose, is approved for the treatment of alcohol and opioid dependence. However, at low doses, it has a paradoxical immunomodulating effect, reducing inflammation and autoimmune activity. This has led to its experimental use for a range of conditions, including chronic pain and autoimmune diseases, and more recently, for hair loss like alopecia areata. Low-dose Naltrexone (LDN) is being investigated for its potential to promote hair regrowth in both men and women by modulating the immune response involved in hair loss.

Used for: Alopecia Areata